GDF15 antagonism limits severe heart failure and prevents cardiac cachexia
Minoru Takaoka(University of Cambridge), Jane Goodall, Stephen O’Rahilly(Wellcome/MRC Institute of Metabolic Science), Borja Ibáñez, J. Harrison(Culham Science Centre), Marcus Au(University of Cambridge), Jasper Tromp(University Medical Center Groningen), Adriaan A. Voors, Xiaohui Zhao(Xi'an Jiaotong University), Eduardo Oliver(Hammersmith Hospital), Stefan J. Marciniak(Wellcome/MRC Cambridge Stem Cell Institute), Debra Rimmington(University of Cambridge), Anthony P. Coll(University of Cambridge), John A. Tadross(University of Cambridge), Ziad Mallat(Inserm), Ali Al-Hadithi(University of Cambridge), Rocío Villena-Gutiérrez(Spanish National Centre for Cardiovascular Research), Shazia Absar(University of Cambridge)
Cited by 33
Related Papers
ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure 2012: The Task Force for the Diagnosis and Treatment of Acute and Chronic Heart Failure 2012 of the European Society of Cardiology. Developed in collaboration with the Heart Failure Association (HFA) of the ESC
|European Heart Journal|2012|6.9k
ESC Guidelines for the Diagnosis and Treatment of Acute and Chronic Heart Failure 2012
|European Journal of Heart Failure|2012|2.6k
The <i>GPR54</i> Gene as a Regulator of Puberty
|New England Journal of Medicine|2003|2.5k
2024 ESC Guidelines for the management of atrial fibrillation developed in collaboration with the European Association for Cardio-Thoracic Surgery (EACTS)
|European Heart Journal|2024|2.4k
2024 ESC Guidelines for the management of chronic coronary syndromes
|European Heart Journal|2024|2.3k